Medical Marijuana, Inc. is globally known as one of the originators in the Hemp/CBD and supplement landscape. Today they continue to make significant advancements in this international movement, a product movement that has proven to assist many people around the world. Take a look back at the top six achievements our family of companies have realized over the past 11 years:
#1 – Launching the first publicly traded cannabis company in the U.S.
Our story began in march of 2009, when Medical Marijuana, Inc. became the first company within the cannabis space to be publicly traded on the U.S. stock market. This represented an important milestone in mainstreams acceptance of the cannabis industry. Today, there are over 50 publicly traded cannabis companies on the United States market.
#2 – Establishing a global CBD pipeline
In 2010, Medical Marijuana, Inc. became the first company to sell cannabis-based products through direct sales and network marketing channels. Our subsidiary Kannaway started to distribute and promote its one-of-a-kind hemp products through thousands of its brand ambassador partnerships. One year later, we established the first ever global CBD pipeline, making cannabidiol and other beneficial cannabinoides available to people in need all over the world.
#3 – Bringing the first CBD hemp oil products to market
In 2012 we were first again by making CBD products available nationwide thru the launch of our Dixie Botanicals line. For the first time consumers could enjoy the various benefits of CBD that’s being provided by the hemp plant. Dixie Botanicals now became the first mainstream, natural, botanical CBD brand in the U.S. Dixie also released the introduction of CBD foods and supplements into the mainstream market.
Eight years previous, few people had ever heard of CBD and the wellness benefits it could provide. As people experienced remarkable results from CBD oil, it became recognized as one of the most beneficial supplements available.
#4 – Licensing the U.S. government patent on cannabinoids
In 2012, our subsidiary Kannalife Sciences was issued the first ever licenses allowing them to develop and commercialize drug treatments under the United States government’s patent 6330507 – “Cannabinoids as Antioxidants & Neuroprotectants”. The company is utilizing these Intellectual Properties to develop cannabinoid based pharmaceutical treatments for a pair of neurological diseases: hepatic encephalopathy and chronic traumatic encephalopathy – the degenerative brain disease discovered in many NFL football players and other athletes who experienced head trauma.
#5 – Legalizing CBD oil in Brazil
By 2014, word of CBD’s benefits had begun traveling around the world. In that year, Medical Marijuana, Inc. product, RSHO™ became the first ever medical cannabis product to be approved for import to Brazil, and this was due to a little girl being granted access to CBD. Soon after, HempMeds Brasil was created to help patients gain access to CBD throughout the country.
In 2015, following Brazil’s approval of CBD importation, HempMeds Brasil became the first company to have a cannabis-based product subsidized by a national government. In the same year, RSHO™ became the first CBD product to also be prescribed for Alzheimer’s Disease, Parkinson’s Disease, chronic pain, and migraines in Brazil. Now, HempMeds Brasil supports thousands of families and patients through its network of hundreds of doctors around the country.
#6 – Legalizing CBD oil in Mexico and other Latin American countries
Two years later, we were able to assist patients in Mexico by securing the first-ever official certificates to import RSHO™ CBD oil products in to the country. Similar to the road map in Brazil, Medical Marijuana, Inc. worked with families and patients in Mexico to petition the government for access to CBD through a new subsidiary, HempMeds Mexico. In order to fulfill Mexico’s regulations and ship our CBD oil to patients, we developed the first ever THC free hemp oil product, RSHO-X.
Medical Marijuana, Inc. also became the first company to have cannabis products approved and sold in Puerto Rico and Paraguay. Through our expansion and tireless efforts, now over 300 million people have legal access to CBD in Central and South America.